These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9236898

  • 1. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
    Lee CS.
    Eur J Surg Oncol; 1997 Jun; 23(3):233-7. PubMed ID: 9236898
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours.
    Lee CS.
    Eur J Surg Oncol; 1998 Feb; 24(1):38-42. PubMed ID: 9542514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS, Pirdas A.
    Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
    [Abstract] [Full Text] [Related]

  • 5. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS.
    Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306
    [Abstract] [Full Text] [Related]

  • 6. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M, Wee A, Raju GC.
    Cancer; 1994 Sep 01; 74(5):1542-5. PubMed ID: 7520348
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours.
    Lee CS, Pirdas A.
    Pathol Res Pract; 1995 Nov 01; 191(11):1087-91. PubMed ID: 8822109
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC, Lee KT, Tsai KB, Sheen PC, Nagai E, Mizumoto K, Tanaka M.
    World J Surg; 2004 Oct 01; 28(10):995-1000. PubMed ID: 15573254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas.
    Yanagisawa N, Mikami T, Koike M, Okayasu I.
    Histopathology; 2000 Jan 01; 36(1):54-61. PubMed ID: 10632753
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.